Ketone drinks may sharpen the mind and boost stamina in exhausted cyclists

NCT ID NCT07792876

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 28, 2026 · Last updated Aug 28, 2026

Summary

This crossover trial gives 12 amateur cyclists three different drinks during separate 3-hour cycling sessions: carbs alone, carbs plus ketones, or a placebo. Researchers measure how far they ride in a final 20-minute sprint, how well they perform on computer tests of memory and attention, and how their blood responds. The goal is to see whether ketone supplementation preserves cognitive function and enhances physical performance during exhaustive exercise, possibly through anti-inflammatory effects.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Ketone supplement (exogenous ketones) taken as a drink alongside a carbohydrate beverage
What this could lead to
If ketones help, athletes might use them to sustain mental focus and physical output during long races, possibly pointing to broader benefits for brain and muscle under stress.
What could go wrong
The trial is small (12 cyclists) and early, so results may not apply to other athletes or activities. Ketone drinks can also cause stomach discomfort, which might offset any benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 12 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2025

Expected to finish

Jan 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 50 years

Sex

Male participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Amateur male cyclists; * At least 2 years of cycling experience; * At least 5 hours of endurance cycling training per week; * VO2max of at least 50 mL/kg/min. Exclusion Criteria: * Confirmed diagnosis of COVID-19 by PCR or rapid antigen test within the last 12 months; * Symptoms compatible with COVID-19 within the last six months; * Smokers; * Alcoholics; * Presence of neurological, immune, or muscular diseases; * Use of psychoactive medications in the last year; * Use of any acute medication prior three days each visit that possible could affect the experiment such as stool-altering medications and non-steroidal anti-inflammatory drugs; * Confirmed gastrointestinal infections, diseases, or disorders (e.g., coeliac disease, inflammatory bowel disease, irritable bowel syndrome, diverticular disease, gastroesophageal reflux disease); * Medical history of gastrointestinal surgery, or any other self-reported gastrointestinal issues; * Within the previous three months, if they had consumed substances that could affect gastrointestinal integrity or followed gastrointestinal-targeted dietary regimes; * Participants with any food allergy should be excluded of this study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Athletic performance are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Ketosis Motor Activity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • School of Physical Education and Sport of Ribeirão Preto - University of São Paulo

    RECRUITING

    Ribeirão Preto, São Paulo, 14040-900, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.